iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Sees Significant Increase in Short Interest

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) saw a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 8,781 shares, an increase of 30.1% from the January 15th total of 6,747 shares. Based on an average daily trading volume, of 52,967 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.2% of the company’s shares are short sold. Currently, 0.2% of the company’s shares are short sold. Based on an average daily trading volume, of 52,967 shares, the days-to-cover ratio is currently 0.2 days.

Institutional Investors Weigh In On iShares Genomics Immunology and Healthcare ETF

Several hedge funds have recently bought and sold shares of the business. Portland Global Advisors LLC purchased a new stake in shares of iShares Genomics Immunology and Healthcare ETF in the second quarter worth approximately $2,099,000. Flow Traders U.S. LLC acquired a new position in iShares Genomics Immunology and Healthcare ETF during the second quarter worth $931,000. Ameriprise Financial Inc. raised its holdings in iShares Genomics Immunology and Healthcare ETF by 8.4% during the third quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock valued at $1,688,000 after buying an additional 5,540 shares in the last quarter. Finally, Triumph Capital Management acquired a new stake in shares of iShares Genomics Immunology and Healthcare ETF in the third quarter worth about $35,000.

iShares Genomics Immunology and Healthcare ETF Stock Performance

Shares of NYSEARCA:IDNA traded up $0.27 during mid-day trading on Tuesday, hitting $29.33. The stock had a trading volume of 10,868 shares, compared to its average volume of 46,018. iShares Genomics Immunology and Healthcare ETF has a 12-month low of $17.26 and a 12-month high of $30.30. The company has a market cap of $146.65 million, a PE ratio of 14.76 and a beta of 1.07. The company’s 50 day moving average is $27.78 and its 200-day moving average is $25.38.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.